| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 289.503 | 87 |
| GSM780708 | Untreated after 4 days (C2_1) | 198.481 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 205.854 | 84 |
| GSM780719 | Untreated after 4 days (C1_2) | 268.107 | 86 |
| GSM780720 | Untreated after 4 days (C2_2) | 230.06 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 210.999 | 84 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 205.005 | 84 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 232.39 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 266.15 | 86 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 195.723 | 83 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 254.233 | 86 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 298.444 | 87 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 316.682 | 88 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 251.054 | 86 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 274.637 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 288.726 | 87 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 234.068 | 85 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 266.194 | 86 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 225.478 | 85 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 198.135 | 83 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 233.669 | 85 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 221.706 | 85 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 221.749 | 85 |